Document Detail


Genomic medicine: bringing biomarkers to clinical medicine.
MedLine Citation:
PMID:  16006183     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
An important by-product of sequencing the human genome has been the development of a novel 'toolbox' for biomarker discovery and development. Genomic medicine is an emerging discipline in the genome sciences that integrates these tools to interrogate genomic variation in well-defined populations in order to develop predictors of disease susceptibility, progression and drug response. Several important classes of biomarkers result from these analyses which, when translated to clinical medicine and drug development, will have an important impact on human health and disease. This review highlights both the opportunities and challenges in bringing biomarkers into clinical medicine.
Authors:
David Seo; Geoffrey S Ginsburg
Related Documents :
11079973 - Development of the spanish version of the systematized nomenclature of medicine: method...
10676833 - Management protocol for abacavir-related hypersensitivity reaction.
1683233 - Cytotoxicity of tiazofurin and its arabinose and xylose analogues in k562 cells.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Current opinion in chemical biology     Volume:  9     ISSN:  1367-5931     ISO Abbreviation:  Curr Opin Chem Biol     Publication Date:  2005 Aug 
Date Detail:
Created Date:  2005-07-25     Completed Date:  2005-11-01     Revised Date:  2009-08-25    
Medline Journal Info:
Nlm Unique ID:  9811312     Medline TA:  Curr Opin Chem Biol     Country:  England    
Other Details:
Languages:  eng     Pagination:  381-6     Citation Subset:  IM    
Affiliation:
Center for Genomic Medicine, Institute for Genome Sciences and Policy, Duke University Medical Center, Durham, NC 27710, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Clinical Medicine / methods*,  trends*
Genetic Markers*
Genomics / trends*
Humans
Pharmacogenetics / trends
Chemical
Reg. No./Substance:
0/Genetic Markers

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Recent applications of protein crystallography and structure-guided drug design.
Next Document:  The spectrum of enzymes involved in activation of 2-aminoanthracene varies with the metabolic system...